Chromosomal fragile sites and relationship between genetic predisposition to small cell lung cancer

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 22, Issue 1, 2002, Pages 31-40

  Karada, M ^a   Tunca, B ^a   Cecener G ^a   Egeli, ^a   Ozyardimci N ^a   Ege, E ^a   Gozu O ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Chromosome aberration; Common fragile sites; Genetic predisposition; Peripheric blood lymphocyte cultures; Small cell lung cancer

Indexed keywords

APHIDICOLIN;

ADULT; AGED; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 7Q; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILITY; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC STABILITY; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; MALE; METAPHASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RELATIVE;

ADOLESCENT; ADULT; AGED; CARCINOMA, SMALL CELL; CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN; CYTOGENETICS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; PEDIGREE;

MAMMALIA;

EID: 0036135197     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/tcm.1036     Document Type: Article

References (31)

1. Comparative study of chromosome aberrations induced with aphidicolin in women affected by breast cancer and cervix uterine cancer
2. Report of the committee on cytogenetic markers
3. A study on lymphocytes of neuroblastoma patients
4. Patients with different lung cancer show expression of fra(3)(p14) in aphidicolin treated lymphocytes cultures
5. Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer
6. The expression frequency of common fragile sites and genetic susceptibility to lung cancer
7. Fragile sites induction by aphidicolin may be increased in parents of neuroblastoma patients
8. The expression of common fragile sites and genetic predisposition to squamous cell lung cancers
9. Common fragile site expression and genetic predisposition to breast cancer
10. The expression frequency of common fragile sites and genetic predisposition to colon cancer
11. The Expression of fragile sites in lymphocytes of patients with rectum cancer and their relatives
12. The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites
13. The expression of aphidicolin induced fragile sites in familial breast cancer patients
14. Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangements in acute myelomonocytic leukaemia
15. No statistical association between common fragile sites and nonrandom chromosome breakpoints in cancer cells
16. Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies
17. Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogens
18. Mutagen sensitivity: A biological marker of cancer susceptibility
19. Specific chromosome anomalies and predisposition to human breast, renal cell and colorectal carcinomas
20. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer
21. Molecular analysis of the short arm of chromosome 3 in small-cell and non-smal-cell carcinoma of the lung
22. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma
23. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors
24. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease- associated, and familial pheochromocytoma
25. Loss of heterozygosity for a chromosome 3 sequence presumably at 3p21 in small cell lung cancer
26. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines
27. The FHIT gene at 3p14.2 is abnormal in lung cancer
28. Evaluation of the FHIT gene in colorectal cancers
29. Deletion of DNA sequence at the chromosomal region 3p21 in all major types of lung cancer
30. Constitutive fragile sites and cancer
31. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer patients